MEI Pharma Says Board Approved Adoption Of Limited-Duration Stockholder Rights Plan; Responds To Substantial Stock Accumulation By Anson Advisors And Cable Car Capital

Author: Benzinga Newsdesk | October 02, 2023 06:06am

The Board of Directors resolved to adopt the Rights Plan following the recent Schedule 13D amendments filed by Anson Advisors and Cable Car Capital LLC, in which the Anson and Cable Car Group disclosed that they and their affiliates have acquired a position that represents approximately 19.9% of the outstanding shares. The rights will initially trade with MEI Pharma's common stock and will become exercisable only if any person acquires 20% or more of the Company's outstanding common stock. The Rights Plan is effective immediately and will expire on September 30, 2024.

Posted In: MEIP